Related references
Note: Only part of the references are listed.Gene therapy using haematopoietic stem and progenitor cells
Giuliana Ferrari et al.
NATURE REVIEWS GENETICS (2021)
Hematopoietic Stem Cell-Targeted Gene-Addition and Gene-Editing Strategies for b-hemoglobinopathies
Claire M. Drysdale et al.
CELL STEM CELL (2021)
Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both, or neither
Richard J. Jones et al.
BLOOD (2021)
Review of the Pharmacokinetics and Pharmacodynamics of Intravenous Busulfan in Paediatric Patients
Rachael Lawson et al.
CLINICAL PHARMACOKINETICS (2021)
Interim Results from the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies of Betibeglogene Autotemcel Gene Therapy (LentiGlobin) for the Treatment of Transfusion-Dependent β-Thalassemia
Jennifer Schneiderman et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones
Frederic D. Bushman
MOLECULAR THERAPY (2020)
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Matthew M. Hsieh et al.
BLOOD ADVANCES (2020)
HIV proviral DNA integration can drive T cell growth ex vivo
John K. Yoon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
The E3 ligase UBR2 regulates cell death under caspase deficiency via Erk/MAPK pathway
Elodie Villa et al.
CELL DEATH & DISEASE (2020)
Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+Hematopoietic Stem and Progenitor Cells
Haydar Frangoul et al.
BLOOD (2020)
Early Results from a Phase 1/2 Study of Aru-1801 Gene Therapy for Sickle Cell Disease (SCD): Manufacturing Process Enhancements Improve Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant
Michael Grimley et al.
BLOOD (2020)
Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature
Yang Li et al.
MODERN PATHOLOGY (2019)
Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies
Elisa Magrin et al.
BLOOD (2019)
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent β-thalassemia
Sarah Marktel et al.
NATURE MEDICINE (2019)
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant
Christopher Strouse et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hematopoietic Cell Transplantation in Thalassemia and Sickle Cell Disease: Report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry: 2000-2017
Donatella Baronciani et al.
BLOOD (2018)
INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes
Eric Sherman et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions
Charles C. Berry et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Increased risk of leukemia among sickle cell disease patients in California
Ann Brunson et al.
BLOOD (2017)
Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Jorge Mansilla-Soto et al.
HUMAN GENE THERAPY (2016)
Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study
Olena O. Seminog et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2016)
Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis
Imke H. Bartelink et al.
Lancet Haematology (2016)
Comparing DNA integration site clusters with scan statistics
Charles C. Berry et al.
BIOINFORMATICS (2014)
Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
Farid Boulad et al.
BLOOD (2014)
IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
Petros Kountouris et al.
PLOS ONE (2014)
Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo
Jingping Hu et al.
BLOOD (2013)
Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia
Giorgio La Nasa et al.
BLOOD (2013)
HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway
Kyung-Rok Yu et al.
STEM CELL RESEARCH (2013)
Estimating abundances of retroviral insertion sites from DNA fragment length data
Charles C. Berry et al.
BIOINFORMATICS (2012)
Deregulated expression of HMGA2 is implicated in clonal expansion of PIGA deficient cells in paroxysmal nocturnal haemoglobinuria
Yoshiko Murakami et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Hematopoietic Stem Cell Transplantation in Thalassemia and Sickle Cell Anemia
Guido Lucarelli et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
A Simple and Effective Method to Generate Lentiviral Vectors for Ex Vivo Gene Delivery to Mature Human Peripheral Blood Lymphocytes
Shicheng Yang et al.
HUMAN GENE THERAPY METHODS (2012)
3′UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice
Kazuhiko Ikeda et al.
BLOOD (2011)
The challenge of haemoglobinopathies in resource-poor countries
David J. Weatherall
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population
Vassilis Ladis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction
S. Charrier et al.
GENE THERAPY (2011)
Therapy for beta-globinopathies: a brief review and determinants for successful and safe correction
Ajay Perumbeti et al.
COOLEY'S ANEMIA: NINTH SYMPOSIUM (2010)
Successful correction of murine sickle cell disease with reduced stem cell requirements reinforced by fractionated marrow infusions
Hady Felfly et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation
Sarah Marktel et al.
PEDIATRIC TRANSPLANTATION (2010)
Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in β-thalassemic mice
Leszek Lisowski et al.
BLOOD (2007)
Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patient
Harutaka Katano et al.
MICROBES AND INFECTION (2007)
Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy
A. M. Saito et al.
BONE MARROW TRANSPLANTATION (2007)
Molecular therapies in β-thalassaemia
Lynn Quek et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Therapeutic options for patients with severe beta-thalassemia: The need for globin gene therapy
Michel Sadelain et al.
HUMAN GENE THERAPY (2007)
Lineage-specific activators affect β-globin locus chromatin in multipotent hematopoietic progenitors
Stefania Bottardi et al.
EMBO JOURNAL (2006)
Costs of allogeneic hematopoietic stem cell transplantation
Britt-Marie Svahn et al.
TRANSPLANTATION (2006)
Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia
Michel Sadelain
CURRENT OPINION IN HEMATOLOGY (2006)
A prospective study of hepatocellular carcinoma incidence in thalassemia
A Mancuso et al.
HEMOGLOBIN (2006)
Gene therapy for the hemoglobin disorders
DA Persons et al.
SEMINARS IN HEMATOLOGY (2004)
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer
S Rivella et al.
BLOOD (2003)
Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene
C May et al.
BLOOD (2002)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
Share Paper
